Research Areas
In ths section, by far, most Axon Ligands™ are categorized as research tools that find their application in cell signaling and oncology. Targeting a multitude of specific enzymes and receptors, they either stimulate or block particular cellular signaling pathways that are implicated in various kinds of cancer. Naturally, all products in this section can also be found by their specific biological targets as listed in the sections of enzymes, receptors, transcription factors, proteins and/or signaling pathways. Besides the comprehensive set of compounds that targe cell signaling and oncology, selections of Axon Ligands™ have also been made for other research area's such as cardiovascular diseases, angiogenisis, epigenetics, stem cell research, among many others.
Axon ID | Name | Description | From price | |
---|---|---|---|---|
3256 | Zileuton | Potent and orally active inhibitor of 5-lipoxygenase (5-LOX) | Recently added | €50.00 |
2106 | Valdecoxib | Selective COX-2 inhibitor | €80.00 | |
2844 | ThioLox | Inhibitor of 15-lipoxygenase-1 (15-LOX-1) | €120.00 | |
2108 | SC 236 | Selective COX-2 inhibitor | €80.00 | |
3311 | Parecoxib sodium | Prodrug of Valdecoxib; selective COX-2 inhibitor | Recently added | €50.00 |
2873 | ML 355 | Potent and selective inhibitor of 12-lipoxygenase (LOX) | €95.00 | |
2312 | ML 351 | Potent and selective inhibitor of 12/15-lipoxygenase (LOX) | €125.00 | |
1974 | GW 406381 | COX-2 inhibitor | €105.00 | |
3126 | Flurbiprofen | COX-inhibitor; NSAID | €50.00 | |
3176 | Diethylcarbamazine citrate | Filaricidal drug | €40.00 | |
1919 | Celecoxib | Selective COX-2 inhibitor | €50.00 | |
2288 | ATB 346 | Orally active hydrogen sulfide-releasing cyclooxygenase inhibitor | €110.00 | |
2989 | 15-LOX-1 inhibitor i472 | Inhibitor of 15-lipoxygenase-1 (15-LOX-1) | €165.00 |